Publications
2 shownOlaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
In patients with advanced ovarian cancer receiving first-line standard therapy including bevacizumab, the addition of maintenance olaparib provided a significant progression-fre...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,600
- Institution
- Centre Léon Bérard
External Links
Identifiers
- ORCID
- 0000-0002-5963-6623
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.